These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11701947)

  • 1. Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR.
    Smith M; Escamilla JR; Filipek P; Bocian ME; Modahl C; Flodman P; Spence MA
    Cytogenet Cell Genet; 2001; 94(1-2):15-22. PubMed ID: 11701947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion 2q37.3 and autism: molecular cytogenetic mapping of the candidate region for autistic disorder.
    Lukusa T; Vermeesch JR; Holvoet M; Fryns JP; Devriendt K
    Genet Couns; 2004; 15(3):293-301. PubMed ID: 15517821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndrome.
    Felder B; Radlwimmer B; Benner A; Mincheva A; Tödt G; Beyer KS; Schuster C; Bölte S; Schmötzer G; Klauck SM; Poustka F; Lichter P; Poustka A
    Am J Med Genet A; 2009 May; 149A(5):952-9. PubMed ID: 19365831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism susceptibility gene.
    Wassink TH; Piven J; Vieland VJ; Jenkins L; Frantz R; Bartlett CW; Goedken R; Childress D; Spence MA; Smith M; Sheffield VC
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):36-44. PubMed ID: 15892143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of chromosome 2q37 and autism: a distinct subtype?
    Ghaziuddin M; Burmeister M
    J Autism Dev Disord; 1999 Jun; 29(3):259-63. PubMed ID: 10425588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 2 (2p16) abnormalities in Carney complex tumours.
    Matyakhina L; Pack S; Kirschner LS; Pak E; Mannan P; Jaikumar J; Taymans SE; Sandrini F; Carney JA; Stratakis CA
    J Med Genet; 2003 Apr; 40(4):268-77. PubMed ID: 12676898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R.
    Ramanathan S; Woodroffe A; Flodman PL; Mays LZ; Hanouni M; Modahl CB; Steinberg-Epstein R; Bocian ME; Spence MA; Smith M
    BMC Med Genet; 2004 Apr; 5():10. PubMed ID: 15090072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal 2q37 deletion and autistic behaviour.
    Lukusa T; Smeets E; Vogels A; Vermeesch JR; Fryns JP
    Genet Couns; 2005; 16(2):179-80. PubMed ID: 16080299
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype.
    Shrimpton AE; Braddock BR; Thomson LL; Stein CK; Hoo JJ
    Clin Genet; 2004 Dec; 66(6):537-44. PubMed ID: 15521982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracentric inversion of chromosome 2 associated with cryptic duplication of 2q14 and deletion of 2q37 in a patient with autism.
    Devillard F; Guinchat V; Moreno-De-Luca D; Tabet AC; Gruchy N; Guillem P; Nguyen Morel MA; Leporrier N; Leboyer M; Jouk PS; Lespinasse J; Betancur C
    Am J Med Genet A; 2010 Sep; 152A(9):2346-54. PubMed ID: 20684015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion 2q37 syndrome: Cognitive-behavioral trajectories and autistic features related to breakpoint and deletion size.
    Fisch GS; Falk RE; Carey JC; Imitola J; Sederberg M; Caravalho KS; South S
    Am J Med Genet A; 2016 Sep; 170(9):2282-91. PubMed ID: 27282419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion 2q37: an identifiable clinical syndrome with mental retardation and autism.
    Galasso C; Lo-Castro A; Lalli C; Nardone AM; Gullotta F; Curatolo P
    J Child Neurol; 2008 Jul; 23(7):802-6. PubMed ID: 18658079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients.
    Leroy C; Landais E; Briault S; David A; Tassy O; Gruchy N; Delobel B; Grégoire MJ; Leheup B; Taine L; Lacombe D; Delrue MA; Toutain A; Paubel A; Mugneret F; Thauvin-Robinet C; Arpin S; Le Caignec C; Jonveaux P; Beri M; Leporrier N; Motte J; Fiquet C; Brichet O; Mozelle-Nivoix M; Sabouraud P; Golovkine N; Bednarek N; Gaillard D; Doco-Fenzy M
    Eur J Hum Genet; 2013 Jun; 21(6):602-12. PubMed ID: 23073310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant Cri du Chat phenotype and autism spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2 and 3p24.3-25 detected using whole genomic array CGH.
    Harvard C; Malenfant P; Koochek M; Creighton S; Mickelson EC; Holden JJ; Lewis ME; Rajcan-Separovic E
    Clin Genet; 2005 Apr; 67(4):341-51. PubMed ID: 15733271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtelomeric region of chromosome 2 in patients with autism spectrum disorders.
    Barbosa-Gonçalves A; Vendrame-Goloni CB; Martins AL; Fett-Conte AC
    Genet Mol Res; 2008 Jun; 7(2):527-33. PubMed ID: 18752177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a 1-megabase deletion in 15q22-q23 in an autistic patient: identification of candidate genes for autism and of homologous DNA segments in 15q22-q23 and 15q11-q13.
    Smith M; Filipek PA; Wu C; Bocian M; Hakim S; Modahl C; Spence MA
    Am J Med Genet; 2000 Dec; 96(6):765-70. PubMed ID: 11121177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of a cryptic 2q37 deletion in a patient with Albright hereditary osteodystrophy-like phenotype.
    Chassaing N; De Mas P; Tauber M; Vincent MC; Julia S; Bourrouillou G; Calvas P; Bieth E
    Am J Med Genet A; 2004 Aug; 128A(4):410-3. PubMed ID: 15264288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer.
    Cengiz B; Gunduz M; Nagatsuka H; Beder L; Gunduz E; Tamamura R; Mahmut N; Fukushima K; Ali MA; Naomoto Y; Shimizu K; Nagai N
    Oral Oncol; 2007 Mar; 43(3):241-7. PubMed ID: 16857411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two further AHO-like syndrome patients with deletion of glypican 1 gene region in 2q37.2-q37.3.
    Polityko A; Maltseva O; Rumyantseva N; Khurs O; Seidel J; Claussen U; Weise A; Liehr T; Starke H
    Int J Mol Med; 2004 Dec; 14(6):977-9. PubMed ID: 15547662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Xp contiguous deletion syndrome and autism.
    Shinawi M; Patel A; Panichkul P; Zascavage R; Peters SU; Scaglia F
    Am J Med Genet A; 2009 Jun; 149A(6):1138-48. PubMed ID: 19441126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.